Melasma and Skin Devices: The Treatment Risks You Shouldn't Overlook

Melasma sits in a category of its own among pigmentation conditions: it is chronic, hormonally driven, and UV-sensitive in ways that make device-based treatment far more complicated than a before-and-after photograph suggests. For Indian patients, that complexity compounds. The majority of people seeking treatment in India have Fitzpatrick skin types IV through VI, skin that carries more active melanocytes and is more prone to post-inflammatory hyperpigmentation (PIH) when heat or trauma is applied to it. Most device protocols were developed and studied on lighter skin types. That gap matters more than most clinic consultations acknowledge.

Melasma is not a fixed deposit of excess pigment. It is a condition of chronically overactive melanocytes, pigment-producing cells in the basal layer of the epidermis, that continue to respond to triggers even after treatment clears visible colour. The three main triggers are UV radiation, oestrogen (including from oral contraceptives and pregnancy), and heat. In India, the UV index in most metros remains high for eight to ten months of the year. A patient who undergoes a laser session in October and resumes commuting without rigorous sun protection can see the pigment return within weeks, not months. The device did not fail; the trigger was never removed.

The most commonly used devices for melasma in Indian clinics are Q-switched Nd:YAG lasers, fractional lasers, and intense pulsed light (IPL). Each targets melanin using a different mechanism. Q-switched Nd:YAG delivers very short pulses of 1064 nm or 532 nm wavelength energy that shatter melanin granules into particles small enough for the immune system to clear. Fractional lasers create columns of controlled thermal injury that trigger remodelling of the dermis and, incidentally, remove some epidermal pigment. IPL delivers broad-spectrum light that melanin absorbs preferentially over surrounding tissue.

The problem with all three in higher Fitzpatrick types is that the margin between the energy level that clears pigment and the level that injures surrounding melanocytes is narrow. An injured melanocyte responds by producing more melanin. PIH from a laser session can be darker and more persistent than the original melasma. Experienced practitioners work at lower fluences with longer intervals between sessions precisely to stay inside that margin, which means the protocol is slower and the result more modest than aggressive marketing implies. Dermal melasma, pigment deposited below the dermal-epidermal junction rather than in the epidermis, responds poorly to most devices regardless of skin type, because the energy is absorbed before it reaches the deeper layer at a concentration sufficient to clear it.

Roughly 90 percent of melasma cases occur in women, and oestrogen is a direct stimulant of melanocyte activity. A patient who is on a combined oral contraceptive pill or who becomes pregnant during a treatment course is exposing her melanocytes to a constant hormonal signal that counteracts whatever the device achieved. No laser protocol can outpace an active hormonal trigger. This is not a contraindication that all clinics discuss clearly before booking a course of sessions. A practitioner who does not ask about contraceptive use and recent hormonal changes before designing a treatment plan is working without information that directly affects the outcome.

When melasma is predominantly epidermal, the hormonal trigger is managed or absent, sun protection is consistent and rigorous, and the treating practitioner has experience with higher Fitzpatrick types, device treatment can produce meaningful lightening. The word meaningful here means a reduction in contrast and area, not elimination. Maintenance is ongoing. Most patients who achieve a good result will see some recurrence within six to twelve months if they discontinue topical maintenance and sun protection. That is the realistic picture, and it is different from the one implied by a course of six sessions priced as a package.

People who should think carefully before proceeding include those with active or recent pregnancy, those on oestrogen-containing contraception who are not prepared to discuss a change with their gynaecologist, anyone with a history of PIH after previous skin treatments, and anyone who cannot commit to daily broad-spectrum SPF 50 use year-round. Melasma that has not been assessed to determine whether it is epidermal, dermal, or mixed, typically done with a Wood's lamp examination, is melasma being treated without enough information. That assessment should happen before any device is chosen.

The condition is manageable for many people, but the path runs through consistent sun protection, hormonal awareness, and a practitioner who will tell you when a device is not the right starting point, not through a device alone. A dermatologist who specialises in pigmentation disorders can assess your specific type, skin tone, and trigger profile and give you a treatment plan built around those facts rather than around what equipment the clinic owns.

Discover expert advice and the latest updates in Skin Care, Hair Care, Wellness, Dermatology, and more at Stay Young guide to lasting beauty and holistic health!